Asia-Pacific Mobile Payments Services Market Outlook and Forecasts 2020-2025 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Mobile Payments Services Market, Forecast to 2025" report has been added to…
6 years ago
Wire Stories
Bolt Bikes Raises US$11M to Supercharge E-bike Business and Rebrand to Zoomo
The Clean Energy Finance Corporation (CEFC) led the round with participation from OneVentures, Viola Credit,…
6 years ago
Zhejiang Export Online Fair Sri Lanka for Household and Hardware Material
COLOMBO, Sri Lanka--(BUSINESS WIRE)--#CREATFoundation--“Zhejiang Export Online Fair (Sri Lanka - Household and Hardware Materials)” conducted…
6 years ago
CyberRisk Alliance Launches Benchmark Industry Index
Resource Allocation and Efficacy Index tracks deployment of cybersecurity resources, spending and confidence NEW YORK,…
6 years ago
Smartsheet to Acquire Brandfolder Adding Content Management to Workflow Automation Offering
Leader in Digital Asset Management Deepens Smartsheet’s Content Capabilities and Strengthens Product Portfolio for Dynamic…
6 years ago
Greater China Managed Security Services Market Outlook and Forecasts to 2023 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Greater China Managed Security Services Market, Forecast to 2023" report has been added…
6 years ago
Bio-Thera Solutions and BeiGene Announce License, Distribution, and Supply Agreement for Avastin® (Bevacizumab) Biosimilar BAT1706 in China
GUANGZHOU & BEIJING & CAMBRIDGE, Mass--(BUSINESS WIRE)--$BGNE--Bio-Thera Solutions, Ltd., a commercial stage biopharmaceutical company (688177.SH)…
6 years ago
Bio-Thera Solutions and BeiGene Announce License, Distribution, and Supply Agreement for Avastin® (Bevacizumab) Biosimilar BAT1706 in China
GUANGZHOU & BEIJING & CAMBRIDGE, Mass--(BUSINESS WIRE)--$BGNE--Bio-Thera Solutions, Ltd., a commercial stage biopharmaceutical company (688177.SH)…
6 years ago
Wipro and Quaternion Partner to Launch Standard Initial Margin Model (SIMM) Solution
The out-of-the-box offering aims to simplify compliance for financial institutions covered under Uncleared Margin Rules…
6 years ago
Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan
KEYTRUDA Now Approved for Patients With PD-L1-Positive Esophageal Squamous Cell Carcinoma Who Have Progressed After…
6 years ago